Literature DB >> 11870878

Retention of membrane-localized beta-catenin in cells lacking functional polycystin-1 and tuberin.

Hiroyuki Kugoh1, Elena Kleymenova, Cheryl Lyn Walker.   

Abstract

The tuberous sclerosis (TSC) 2 tumor suppressor gene encodes the protein tuberin, which has recently been shown to play a crucial role in the intracellular trafficking of polycystin-1, the product of the polycystic kidney disease (PDK) 1 gene. PKD1 is responsible for most cases of autosomal dominant polycystic kidney disease, which has been described as "neoplasia in disguise." Polycystin-1 is a membrane protein localized to adherens junctions in a complex containing E-cadherin and alpha-, beta-, and gamma-catenins. To determine whether loss of membrane localization of polycystin-1 and E-cadherin affects the function of beta-catenin, beta-catenin localization and signaling were characterized in tuberin-null EKT2 and ERC15 cells and in tuberin-positive TRKE2 cells derived from polycystic, neoplastic, and normal rat kidney epithelial cells, respectively. EKT2 cells lacking tuberin because of inactivation of the Tsc2 gene fail to localize polycystin-1 and E-cadherin appropriately to these junctions. However, beta-catenin was retained at lateral cell membranes in both tuberin-null and tuberin-positive cells. Moreover, gene transcription mediated by beta-catenin T-cell--specific transcription factor complexes showed no differences among EKT2, ERC15, and TRKE2 cells. Thus, beta-catenin was stably retained at the lateral cell membrane in tuberin-null renal cells lacking membrane-localized polycystin-1 and E-cadherin. These data suggest that, although loss of Tsc2 tumor suppressor gene function disrupts normal polycystin-1 function and membrane localization of E-cadherin, normal beta-catenin signaling is retained in tuberin-null cells. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11870878     DOI: 10.1002/mc.10034

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  7 in total

Review 1.  Ciliary dysfunction in polycystic kidney disease: an emerging model with polarizing potential.

Authors:  Robert J Kolb; Surya M Nauli
Journal:  Front Biosci       Date:  2008-05-01

2.  VIP17/MAL expression modulates epithelial cyst formation and ciliogenesis.

Authors:  Vinita Takiar; Kavita Mistry; Monica Carmosino; Nicole Schaeren-Wiemers; Michael J Caplan
Journal:  Am J Physiol Cell Physiol       Date:  2012-08-15       Impact factor: 4.249

3.  A polycystin-1 multiprotein complex is disrupted in polycystic kidney disease cells.

Authors:  Tamara Roitbak; Christopher J Ward; Peter C Harris; Robert Bacallao; Scott A Ness; Angela Wandinger-Ness
Journal:  Mol Biol Cell       Date:  2004-01-12       Impact factor: 4.138

Review 4.  Renal involvement in tuberous sclerosis complex and von Hippel-Lindau disease: shared disease mechanisms?

Authors:  Brian J Siroky; Maria F Czyzyk-Krzeska; John J Bissler
Journal:  Nat Clin Pract Nephrol       Date:  2009-03

5.  Tuberin-deficiency downregulates N-cadherin and upregulates vimentin in kidney tumor of TSC patients.

Authors:  Sitai Liang; Tiffanie Salas; Emre Gencaslan; Baojie Li; Samy L Habib
Journal:  Oncotarget       Date:  2014-08-30

6.  mTOR and S6K1 drive polycystic kidney by the control of Afadin-dependent oriented cell division.

Authors:  Martina Bonucci; Nicolas Kuperwasser; Serena Barbe; Vonda Koka; Delphine de Villeneuve; Chi Zhang; Nishit Srivastava; Xiaoying Jia; Matthew P Stokes; Frank Bienaimé; Virginie Verkarre; Jean Baptiste Lopez; Fanny Jaulin; Marco Pontoglio; Fabiola Terzi; Benedicte Delaval; Matthieu Piel; Mario Pende
Journal:  Nat Commun       Date:  2020-06-24       Impact factor: 14.919

Review 7.  Renal Manifestations of Tuberous Sclerosis Complex.

Authors:  Nikhil Nair; Ronith Chakraborty; Zubin Mahajan; Aditya Sharma; Sidharth K Sethi; Rupesh Raina
Journal:  J Kidney Cancer VHL       Date:  2020-08-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.